{
    "2020-05-31": [
        [
            {
                "time": "",
                "original_text": "华兰生物(002007.SZ)：永新晟康已通过大宗交易减持1.51%的股份 减持股份",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "永新晟康",
                        "大宗交易",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "5月大宗交易井喷！大佬套现超百亿，这些公司被机构买入",
                "features": {
                    "keywords": [
                        "大宗交易",
                        "井喷",
                        "套现",
                        "机构买入"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "减持！华兰生物：股东减持约2756万股 减持股份",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "股东",
                        "减持",
                        "2756万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：股东永新晟康减持1.51%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "永新晟康",
                        "减持",
                        "1.51%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "本周创新高股揭秘：25股获北向资金加仓",
                "features": {
                    "keywords": [
                        "创新高",
                        "北向资金",
                        "加仓"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|周报】CXO表现较好，推荐景气提升细分领域配置价值",
                "features": {
                    "keywords": [
                        "民生医药",
                        "CXO",
                        "景气提升",
                        "配置价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}